Fiche publication


Date publication

décembre 2018

Journal

Thrombosis research

Auteurs

Résumé

Data regarding the use of direct oral anticoagulants (DOACs) for the treatment of acute pulmonary embolism (PE) are sparse. We conducted a prospective multicentre registry study to describe patterns of DOAC prescription for the treatment of acute PE, and the associated risk of 6-month adverse events in daily practice.

Mots clés

Direct oral anticoagulant, Outcomes, Patterns of prescription, Pulmonary embolism

Référence

Thromb. Res.. 2018 Dec 8;174:27-33